← Back to Screener
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD)
Price$0.73
Favorite Metrics
Price vs S&P 500 (26W)-47.40%
Price vs S&P 500 (4W)5.47%
Market Capitalization$8.03M
All Metrics
P/CF (Annual)14.09x
Book Value / Share (Quarterly)$0.47
P/TBV (Annual)2.43x
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-15.59%
10-Day Avg Trading Volume0.02M
EPS (Annual)$-0.00
ROI (Annual)-0.41%
Gross Margin (Annual)21.81%
Cash / Share (Quarterly)$0.02
ROA (Last FY)-0.32%
Cash Flow / Share (Annual)$0.04
P/B Ratio1.56x
P/B Ratio (Quarterly)3.15x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)1.27x
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)2.99x
Quick Ratio (Quarterly)2.50x
3-Month Avg Trading Volume0.06M
52-Week Price Return-29.13%
EV / Free Cash Flow (Annual)24.07x
Tangible BV / Share (Quarterly)$0.46
P/S Ratio (Annual)0.64x
Asset Turnover (Annual)3.69x
52-Week High$2.76
EPS Excl Extra (Annual)$-0.00
26-Week Price Return-38.66%
Quick Ratio (Annual)2.74x
13-Week Price Return-8.42%
Total Debt / Equity (Annual)0.47x
Current Ratio (Quarterly)2.92x
Enterprise Value$10.109
Revenue / Employee (Annual)$0
Pretax Margin (Annual)8.13%
Cash / Share (Annual)$0.07
3-Month Return Std Dev74.67%
ROE (Last FY)-0.60%
EPS Basic Excl Extra (Annual)$-0.00
Total Debt / Equity (Quarterly)0.44x
Revenue / Share (Annual)$1.14
Tangible BV / Share (Annual)$0.44
Price vs S&P 500 (52W)-64.22%
Year-to-Date Return-11.45%
5-Day Price Return15.87%
EPS Normalized (Annual)$-0.00
Net Profit Margin (Annual)7.95%
Month-to-Date Return28.41%
EBITD / Share (Annual)$0.11
Operating Margin (Annual)8.31%
LT Debt / Equity (Annual)0.30x
LT Debt / Equity (Quarterly)0.26x
P/TBV (Quarterly)3.20x
P/B Ratio (Annual)2.38x
Book Value / Share (Annual)$0.45
Price vs S&P 500 (13W)-11.28%
Beta1.42x
P/FCF (Annual)19.12x
52-Week Low$0.37
Industry Peers — Drug Wholesale(9)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Operating Margin (TTM) | Revenue Growth TTM (YoY) | Price |
|---|---|---|---|---|---|
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares | — | — | — | — | $0.73 |
MCKMcKesson Corporation | 32.21x | 39.43% | 1.42% | 15.49% | $866.38 |
CORCencora, Inc. | 41.00x | 101.43% | 0.82% | 7.45% | $327.56 |
CAHCardinal Health, Inc. | 32.26x | 37.17% | 1.04% | 10.13% | $213.99 |
HLFHerbalife Ltd. | 7.71x | 170.70% | -14.76% | 0.89% | $17.02 |
NUSNuSkin Enterprises, Inc. | 2.37x | 20.36% | 16.29% | -14.26% | $7.90 |
COSMCosmos Holdings Inc. Common Stock | — | -74.28% | -23.86% | 6.69% | $0.41 |
WGRXWellgistics Health, Inc. Common Stock | — | -1645.88% | -414.51% | 28.73% | $0.14 |
ZSTKZeroStack Corp. Common Stock | — | -332.01% | -339.14% | — | $7.51 |
HWHHWH International Inc. Common Stock | — | -88.53% | -326.05% | -30.84% | $1.17 |
About
Cellyan Biotechnology Co Ltd operates OTC pharmaceutical supply chain and distribution services for cross-border e-commerce in Mainland China. Through its subsidiaries Joint Cross Border and V-Alliance, the company provides supply chain services and procurement/distribution capabilities, serving importers and e-commerce platforms in this growing market.